Urology
Volume 68, Issue 2, Supplement , Pages 9-16 , August 2006

Development and validation of patient-reported outcomes measures for overactive bladder: A review of concepts

  • Karin S. Coyne

      Affiliations

    • Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland, USA
    • Corresponding Author InformationReprint requests: Karin S. Coyne, PhD, MPH, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, Maryland 20814.
    • Karin S. Coyne is a consultant to Pfizer Inc.
  • ,
  • Andrea Tubaro

      Affiliations

    • Sant’Andrea Hospital, “La Sapienza” University, Rome, Italy
  • ,
  • Linda Brubaker

      Affiliations

    • Departments of Obstetrics, Gynecology, and Urology, Loyola University Medical Center, Maywood, Illinois, USA
    • Linda Brubaker receives research funding from Q-Med, Pfizer Inc, and Allergan and receives consultant/speaker honoraria from Q-Med, Novartis, Pfizer Inc, and Astellas.
  • ,
  • Tamara Bavendam

      Affiliations

    • Pfizer Inc, New York, New York, USA
    • Tamara Bavendam is an employee of Pfizer Inc.

References 

  1. Office of New Drugs and Office of Medical Policy . In: Guidance for Industry Patient-Reported Outcome Measures (Use in Medical Product Development to Support Labeling Claims) . vol. 2006: Rockville, MD: Center for Drug Evaluation and Research (CDER); 2006;
  2. Brubaker L , Chapple C , Coyne KS , et al.   Patient-reported outcomes in overactive bladder (importance for determining clinical effectiveness of treatment) . Urology . 2006;68(suppl 2A):3–8
  3. Boyarsky S , Jones G , Paulson DF , et al.   A new look at bladder neck obstruction by the Food and Drug Administration regulators (guidelines for investigation of benign prostatic hyperplasia) . Trans Am Assoc Genitourin Surg . 1977;68:29–32
  4. Stamey TA . Urinary incontinence in the female . In:  Harrison JH ,  Gittes RF ,  Perlmutter AD , et al. editor. Campbell’s Urology . vol. 2: Philadelphia: WB Saunders; 1979;p. 2272–2293
  5. Naughton MJ , Donovan J , Badia X , et al.   Symptom severity and QOL scales for urinary incontinence . Gastroenterology . 2004;126:S114–S123
  6. Corcos J , Beaulieu S , Donovan J , et al.   Quality of life assessment in men and women with urinary incontinence . J Urol . 2002;168:896–905
  7. Symonds T . A review of condition-specific instruments to assess the impact of urinary incontinence on health-related quality of life . Eur Urol . 2003;43:219–225
  8. Donovan J , Badia X , Corcos J , et al.   Committee 6 (symptom and quality of life assessment) . In:  Abrams P ,  Cardozo L ,  Khoury S , et al. editor. Incontinence . Plymouth, United Kingdom: Plymbridge Distributors, Ltd; 2002;p. 267–316
  9. Gordis L . Assessing the validity and reliability of diagnostic and screening tests . In: Epidemiology . Philadelphia, PA: WB Saunders; 1996;p. 58–76
  10. Fitzpatrick R , Davey C , Buxton MJ , et al.   Evaluating patient-based outcome measures for use in clinical trials . Health Technol Assess . 1998;2:1–73
  11. Chassany O , Sagnier P , Marquis P , et al.   Patient-reported outcomes (the example of health-related quality of life—a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process) . Drug Inf J . 2002;36:209–238
  12. Jaeschke R , Singer J , Guyatt GH . Measurement of health status (ascertaining the minimal clinically important difference) . Control Clin Trials . 1989;10:407–415
  13. Kelleher CJ , Pleil AM , Reese PR , et al.   How much is enough and who says so? The case of the King’s Health Questionnaire and overactive bladder . Br J Obstet Gynaecol . 2004;111:605–612
  14. Wiklund I . Assessment of patient-reported outcomes in clinical trials (the example of health-related quality of life) . Fundam Clin Pharmacol . 2004;18:351–363
  15. Norman GR , Sridhar FG , Guyatt GH , et al.   Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life . Med Care . 2001;39:1039–1047
  16. Crosby RD , Kolotkin RL , Williams GR . Defining clinically meaningful change in health-related quality of life . J Clin Epidemiol . 2003;56:395–407
  17. Wyrwich KW , Tierney WM , Wolinsky FD . Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life . J Clin Epidemiol . 1999;52:861–873
  18. Boyle P . Cultural and linguistic validation of questionnaires for use in international studies (the nine-item BPH-specific quality-of-life scale) . Eur Urol . 1997;32(suppl 2):50–52
  19. Conway K , Uzun V , Vigner S , et al.   Linguistic validation of the Overactive Bladder Questionnaire (OAB-q) into 12 languages . 2004; Presented at the 3rd International Conference on Incontinence; June 26-29,; Monte Carlo, Monaco.
  20. Maneesriwongul W , Dixon JK . Instrument translation process (a methods review) . J Adv Nurs . 2004;48:175–186
  21. Coyne K , Revicki D , Hunt T , et al.   Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire (the OAB-q) . Qual Life Res . 2002;11:563–574
  22. Matza LS , Thompson CL , Krasnow J , et al.   Test-retest reliability of four questionnaires for patients with overactive bladder (the Overactive Bladder Questionnaire (OAB-q), Patient Perception of Bladder Condition (PPBC), Urgency Questionnaire (UQ), and the Primary OAB Symptom Questionnaire (POSQ)) . Neurourol Urodyn . 2005;24:215–225
  23. Cardozo L , Coyne KS , Versi E . Validation of the Urgency Perception Scale . BJU Int . 2005;95:591–596
  24. Bowden A , Colman S , Sabounjian L , et al.   [abstract] Psychometric validation of an Urgency Severity Scale (IUSS) for patients with overactive bladder . 2003; Presented at the 33rd Annual Meeting of the International Continence Society; October 5-9,; Florence, Italy.
  25. Brewster-Jordan JL , Guan Z , Green HL , et al.   Establishing the content validity of the Urinary Sensation Scale (USS) . Washington, DC: International Society for Pharmacoeconomics and Outcomes Research; 2005;
  26. European Agency for the Evaluation of Medicinal Products and Committee for Proprietary Medicinal Products (Note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence) . 2002; London,
  27. Coyne KS , Matza L , Versi E . Urinary urgency (can “gotta go” be measured?) . 2003; Presented at the 10th Annual Conference of the International Society for Quality of Life Research; Prague, Czech Republic; November 12–15,
  28. Coyne KS , Lai J-S , Zycyzynski T , et al.   An overactive bladder symptom and quality-of-life short form (development of the Overactive Bladder Questionnaire Short Form (OAB-q SF)) . 2004; Presented at the 34th Joint Meeting of the International Continence Society and the International Urogynecological Association; August 23-27,; Paris, France.
  29. Coyne KS , Matza LS , Thompson CL . The responsiveness of the Overactive Bladder Questionnaire (OAB-q) . Qual Life Res . 2005;14:849–855
  30. Reese PR , Pleil AM , Okano GJ , et al.   Multinational study of reliability and validity of the King’s Health Questionnaire in patients with overactive bladder . Qual Life Res . 2003;12:427–442
  31. Lubeck DP , Prebil LA , Peeples P , et al.   A health related quality of life measure for use in patients with urge urinary incontinence (a validation study) . Qual Life Res . 1999;8:337–344
  32. Abrams P , Cardozo L , Fall M , et al.   The standardisation of terminology in lower urinary tract function (report from the standardisation sub-committee of the International Continence Society) . Urology . 2003;61:37–49
  33. Brubaker L . Urgency (the cornerstone symptom of overactive bladder) . Urology . 2004;64:12–16
  34. Brubaker L . Urinary urgency and frequency (what should a clinician do?) . Obstet Gynecol . 2005;105:661–667
  35. Staskin DR . The urge to define urgency (a review of three approaches) . Curr Urol Rep . 2004;5:413–415
  36. Chapple CR , Wein AJ . The urgency of the problem and the problem of urgency in the overactive bladder . BJU Int . 2005;95:274–275
  37. Chapple CR , Artibani W , Cardozo LD , et al.   The role of urinary urgency and its measurement in the overactive bladder symptom syndrome (current concepts and future prospects) . BJU Int . 2005;95:335–340
  38. Coyne KS , Matza L , Thompson C , et al.   A comparison of three approaches to analyze urinary urgency as a treatment outcome . 2005; Presented at the 35th Annual Meeting of the International Continence Society; August 28 to September 2,; Montreal, Quebec, Canada.
  39. Abrams P , Avery K , Zyczynski T , et al.   Measuring patient outcomes in OAB (the OAB-q, OAB-q SF, OAB screener and ICIQ-OAB) . [abstract] Neurourol Urodyn . 2004;23:399
  40. Coyne KS , Zhou Z , Bhattacharyya SK , et al.   The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA . BJU Int . 2003;92:948–954
  41. Coyne KS , Zhou Z , Thompson C , et al.   The impact on health-related quality of life of stress, urge and mixed urinary incontinence . BJU Int . 2003;92:731–735
  42. Coyne K , Matza L , Thompson C , et al.   Determining the importance of change in the OAB-q . J Urol . 2006;176:627–632
  43. Kelleher CJ , Cardozo LD , Khullar V , et al.   A new questionnaire to assess the quality of life of urinary incontinent women . Br J Obstet Gynaecol . 1997;104:1374–1379
  44. Homma Y , Uemura S . Use of the short form of King’s Health Questionnaire to measure quality of life in patients with an overactive bladder . BJU Int . 2004;93:1009–1013
  45. Abrams P , Avery K , Gardener N , et al.   The International Consultation on Incontinence Modular Questionnaire . www.iciq.net J Urol . 2006;175:1063–1066 discussion 1066
  46. Matza LS , Zyczynski TM , Bavendam T . A review of quality-of-life questionnaires for urinary incontinence and overactive bladder (which ones to use and why?) . Curr Urol Rep . 2004;5:336–342

PII: S0090-4295(06)00770-9

doi: 10.1016/j.urology.2006.05.042

Urology
Volume 68, Issue 2, Supplement , Pages 9-16 , August 2006